Browsing Tag
KRAS mutant cancer
1 post
A durability breakthrough or early signal? What pelareorep means for resistant colorectal cancer
Can durability redefine MSS colorectal cancer? Discover how Oncolytics Biotech, Inc.’s pelareorep data could shift treatment strategy and market dynamics.